Skip to contentC
China Pharma Holdings, Inc.
C
CPHIChina Pharma Holdings, Inc. Q1 2018 · 10-Q
Revenue$3.62M$3.62M+10.1% vs Q1 2017 Net Income-$293.48K-$293.48KN/M vs Q1 2017 EPS Diluted-$0.01-$0.01N/M vs Q1 2017 Gross Profit$1,053,700+46.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
Operating Cash Flow$523,739+5,264.0% Free Cash Flowderived$520,112N/M Margins · derivedGross margin29.1%+7.3 pt vs Q1 2017
Operating margin-3.9%+20.5 pt vs Q1 2017
Net margin-8.1%+21.3 pt vs Q1 2017
ended Mar 31, 2018 · filed May 14, 2018 · 44 d after period end